首頁 > 市場調查報告書 > 醫療設備

呼吸器

市場調查報告書

商品編碼

1352117

全球氣管管理設備市場 - 2023-2030

Global Airway Management Devices Market - 2023-2030

出版日期: 2023年09月27日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

在各種情況下，從簡單的窒息到複雜的氣管阻塞，個人可能需要氣管管理。氣管阻塞最常見的原因是舌頭或異物阻塞呼吸道。它也可能是氣管損傷、血液和分泌物（例如唾液和黏液）增加或氣管發炎的結果。

此外，氣管管理設備市場受到多種因素的推動，例如呼吸系統疾病盛行率的上升、手術數量的增加、麻醉的使用、醫療保健支出的增加、醫療保健基礎設施的進步以及對醫療設備的高需求。擴大護理服務都有利於氣管管理設備市場。

動力學

呼吸道疾病盛行率上升

呼吸道疾病盛行率的增加是預測期內幫助市場成長的關鍵促進因素之一。由於呼吸系統疾病的增加，氣管管理設備的使用經常被迅速使用，這確實會增加市場的成長。例如，根據疾病管制與預防中心的數據，慢性阻塞性肺病估計影響 2 億人，每年有 320 萬人死亡，使其成為全球第三大死因。

氣喘是最常見的非傳染性疾病之一，影響全球 2.62 億人。預計 2022 年將有近 220 萬例新發肺癌病例和 180 萬人死亡，肺癌佔全球癌症死亡人數的四分之一。下呼吸道感染或肺炎是重要的死亡原因，每年造成超過 240 萬人死亡，主要發生在低收入和中等收入國家 (LMIC)。 COVID-19 顯著增加了全球肺炎死亡人數。

氣管管理技術先進設備開發的興起

開發技術先進的氣管管理設備的成長是幫助氣管管理設備市場在預測期內成長的關鍵驅動力之一。

例如，2022 年 1 月，ICU Medical Inc. 完成了從 Smiths Group PLC 收購 Smiths Medical，增加全球氣管管理設備、重要護理產品、門診輸液設備等產品組合，從而改善患者治療體驗並改善整體成果。

缺乏報銷政策

由於醫療保險計劃薄弱，發展中國家對昂貴的氣管管理設備的採用率較低。根據世界銀行集團的數據，每人每年平均醫療保健支出為 80 美元，這使得人們更容易患慢性病和 COVID-19 流行病。

到 2030 年，54 個最貧困國家的全民健保資金缺口預計將達到 1,760 億美元。視訊喉鏡等醫療設備和複雜手術方法的有限採用限制了氣管管理設備的市場佔有率。

Overview

Airway management may be required for individuals in a variety of circumstances, ranging from simple choking to complicated airway obstruction. Airway obstruction most commonly occurs as a result of the tongue or foreign bodies blocking the airway. It can also be the result of injury to the airway, increased presence of blood and secretions (e.g., saliva and mucus), or inflammation of the airway.

Futhermore, the airway management devices market is driven by various factors like rising prevalence of respiratory diseases, and as the number of surgeries increases, so does the use of anaesthesia, the increase in healthcare spending, advancements in healthcare infrastructure, and a high demand for expanded care delivery all benefit the airway management device market.

Dynamics

Rise in Prevalence of Respiratory Diseases

Increase prevalence of respiratory disease is one the key driver that helps the market to grow during forecast period. Since rise in respiratory diseases the use of airway managmenet devices are often used rapdily which indeed will increase the market growth. For instance, according to the Centres for Disease Control and Prevention COPD affects an estimated 200 million people, with 3.2 million dying each year, making it the third-leading cause of mortality globally.

Asthma is one of the most common noncommunicable illnesses, impacting 262 million people worldwide.With almost 2.2 million new instances of lung cancer expected in 2022 and 1.80 million fatalities, lung cancer accounts for one in every four cancer deaths worldwide. Lower respiratory tract infection or pneumonia is a prominent cause of death, accounting for more than 2.4 million fatalities each year, primarily in low and middle-income countries (LMICs). COVID-19 has significantly increased pneumonia fatalities worldwide.

Rise in Developing Technologically Advanced Devices in Airway Management

Rise in developing technologically advanced devices in airway management is one of the key driver that helps the airway management devices market to grow during the forecast period.

For instance, in January 2022, ICU Medical Inc., completed the acquisition of Smiths Medical from Smiths Group PLC, to increase the product portfolio globally in devices for airway management, vital care products, ambulatory infusion devices, and others to enhance the patient treatment experience and improve overall outcomes.

Lack of Reimbursement Policies

Due to poor healthcare insurance programmes, developing nations have low adoption rates for pricey airway management devices. According to the World Bank Group, the average yearly healthcare expenditure is $80 per person, making the population more prone to chronic sickness and COVID-19 epidemics.

The financial shortfall for universal health care is anticipated to reach $176 billion by 2030 among the 54 poorest countries. The limited adoption of medical equipment such as video laryngoscopes and sophisticated surgical methods restricts the market share of airway management devices.

Segment Analysis

The global airway management devices is segmented based on type, age, end user and region.

The Laryngoscopes From Type Segment Accounted for Approximately 42.5 % of the Airway Management Devices Share

The laryngoscopes from type segment with around 42.5% is expected to dominate during the forecast period. Laryngoscopy is a visual examination using a throat scope to view the larynx, which contains vocal cords. It helps diagnose ear or throat pain, airway blockages, throat narrowing, and swallowing difficulties.

For instance, in April 2022 OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging, analog and touch & display technology, launched new laryngoscope reference designs that include a range of OMNIVISION products that help improve patient care by providing crisp, clear images for single-use video laryngoscopes. Visualization makes insertion of the endotracheal tube easier and faster and avoids failures in difficult airways, significantly reducing the chances of complications and even death.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share in 2022

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to the rising R&D and introduction of new technologies in devices of airway management by key players to help aid in patient treatment is likely to drive the North America market growth. Moreover, increasing collaborations among manufacturing players and rising approvals of new airway devices with extensive presence across the region also drive the this region in future.

For instance, on June 21, 2023 Teleflex Incorporated a leading global provider of medical technologies, announced a partnership with Shenzhen Insighters Medical Technology Co., Ltd. As the exclusive U.S. distributor of the Insighters Video Laryngoscope system, which is designed to inspect the upper glottic airway and facilitate endotracheal intubation.

Competitive Landscape

The major global players in the airway management devices market include: Medtronic , Boston Scientific Corporation , Olympus Corporation, ICU Medical, Inc, ConvaTec Group Plc, KARL STORZ, Teleflex Incorporated , Ambu A/S , Verathon Inc, SourceMark and among others.

COVID-19 Impact Analysis

The COVID-19 epidemic has increased the number of patients admitted to emergency departments and intensive care units. Patients suffering from severe infections typically have respiratory failure or low oxygen saturation, necessitating the use of positive air pressure devices such as ventilators. As a result, demand for airway control devices, particularly single-use devices, is increasing.

As non-invasive methods carry the potential of virus particle aerosolization, the number of patients requiring intubation via invasive airway management procedures has grown. Healthcare practitioners that provide airway management treatment to COVID-19 patients and other patients in healthcare institutions are putting themselves at danger, which has boosted the need for single-use devices.

Russia Ukraine Conflict Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global airway management devices, owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of devices is expected to have little influence over the global airway management devices growth over the forecast period.

By Type

Laryngoscopes
Infraglottic Airway Management Devices
Supraglottic Airway Management Devices
Resuscitators
Cricothyrotomy Kits
Others

By Age

Pediatrics/Neonates
Adults

By End User

Hospitals
Ambulatory Surgical Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe

South America
- Brazil
- Argentina
- Rest of South America

Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific

Middle East and Africa

Key Developments

In Jan 2022 Qure.ai, a health tech firm, received FDA approval for an artificial intelligence (AI) algorithm, qXR-BT, that helps doctors in assessing Breathing Tube (BT) placements. The algorithm helps clinicians locate the BT location and automate measurements for intubated patients using chest X-rays.
In May 2021, Medtronic introduced the SonarMed airway monitoring system, acoustic technology for real-time monitoring of endotracheal tube (ETT) obstruction and position in neonates and infants. This innovative device helps clinicians make informed decisions for life-saving care.
In May 2021, Olympus Corporation announced the FDA clearance of its Airway Mobilescopes, the MAF-TM2, MAF-GM2, and MAF-DM2, enabling providers to perform a variety of upper and lower airway management procedures.

Why Purchase the Report?

To visualize the global airway management devices market segmentation based on type, age, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global airway management devices market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global airway management devices market report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Age
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in Prevalence of Respiratory Diseases
  - 4.1.1.2. Rise in Developing Technologically Advanced Devices in Airway Management
- 4.1.2. Restraints
  - 4.1.2.1. Lack of Reimbursement Policies
- 4.1.3. Opportunity
  - 4.1.3.1. Rising Growth Potential in Developing Countries
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post Covid-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Laryngoscopes *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Infraglottic Airway Management Devices
7.4. Supraglottic Airway Management Devices
7.5. Resuscitators
7.6. Cricothyrotomy Kits
7.7. Other

8. By Age

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
- 8.1.2. Market Attractiveness Index, By Age
8.2. Pediatrics/Neonates*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Adults

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. U.K.
  - 10.3.6.3. France
  - 10.3.6.4. Spain
  - 10.3.6.5. Italy
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan

Australia

10.5.6.4. Rest of Asia-Pacific

10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Medtronic *
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Boston Scientific Corporation
12.3. Olympus Corporation
12.4. ICU Medical, Inc
12.5. ConvaTec Group Plc
12.6. KARL STORZ
12.7. Teleflex Incorporated
12.8. Ambu A/S
12.9. Verathon Inc
12.10. SourceMark

LIST NOT EXHAUSTIVE